HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Enterosan--perspective medications for patients with postinfection irritable bowel syndrome].

AbstractUNLABELLED:
The pathogenesis of PIBS matter transferred intestinal infections that lead to persistent intestinal dysbiosis. The aim of this study was to investigate the effectiveness of enterosana at PIBS.
MATERIALS AND METHODS:
A total of 37 patients with PIBS diarrhea included in the study group and 30 patients consisted the control group. Diagnosis PIBS installed in accordance with the criteria of the Rome Consensus II. To assess the intestinal microflora were sown feces and made hydrogen breath test.
RESULTS:
In the study group patients by the end of the 3-week course enterosan therapy was appeared stable clinical PIBS remission. In the reseeding of feces decreased levels of conditionally pathogenic microflora and increased to normal number of bifidobacteria and lactobacilli. Were normalized rates of hydrogen in exhaled air according to breath test, which reflects bacterial overgrowth in the lumen of the small intestine.
CONCLUSION:
Enterosan has good therapeutic effect in treating patients with PIBS, helps to restore normal intestinal microflora and improve intestinal digestion.
AuthorsA I Parfenov, I N Ruchkina
JournalEksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology (Eksp Klin Gastroenterol) Issue 3 Pg. 102-4 ( 2011) ISSN: 1682-8658 [Print] Russia (Federation)
PMID21695957 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Glycosaminoglycans
  • enterosan
Topics
  • Adult
  • Breath Tests
  • Diarrhea (complications, microbiology)
  • Feces (microbiology)
  • Female
  • Glycosaminoglycans (administration & dosage, therapeutic use)
  • Humans
  • Intestinal Mucosa (drug effects, microbiology)
  • Intestine, Small (drug effects, microbiology)
  • Irritable Bowel Syndrome (drug therapy, etiology, microbiology)
  • Male
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: